Capabilities
Multiparticulate drug delivery, engineered end to end
Oral solid-dosage expertise spanning pelletisation, functional coating and pharmaceutical intermediates, supported by formulation, process and analytical development.
Pharmaceutical pellets
Immediate-, sustained-, delayed- and enteric-release pellets across a broad active range, the core of our multiparticulate expertise.
- Pelletisation and functional coating for immediate, delayed, sustained and extended-release approaches.
- Development considers pellet properties, coating composition and weight gain alongside dissolution performance and release kinetics.
- Semi-finished intermediates for capsule filling, compression or blending, as required by the product programme.
MUPS & multiparticulates
Multi-Unit Pellet Systems and blended multiparticulates enabling fixed-dose combinations in a single dosage unit.
- Multi-Unit Pellet Systems bring individual pellets together within a single dosage unit.
- Blended pellet systems can combine components with different release characteristics.
- Formulation and process development are guided by the intended finished dosage form.
Granules & SUBA granules
Standard and amorphous / enhanced-bioavailability (SUBA-type) granules, including itraconazole formulations.
- Standard granules and amorphous / enhanced-bioavailability (SUBA-type) granules, including itraconazole formulations.
- Taste-masked azithromycin and ciprofloxacin granules, with specifications discussed during a technical enquiry.
- SUBA-type formulation performance and bioequivalence require product-specific evidence.
Taste-masked granules
Enteric & controlled release
Enteric coating and modified-release architectures engineered for site-specific and time-controlled delivery.
- Functional coating supports delayed- and sustained-release formulation approaches.
- Coating composition, coating weight gain and process parameters are considered together.
- Dissolution evaluation and release kinetics inform formulation optimisation.
Finished formulations
Capsules, tablets and sachets, including fixed-dose combinations built from our own multiparticulates.
- Capsules, tablets and sachets, including fixed-dose combinations.
- Intermediates are developed with physical, chemical and functional properties suited to capsule filling, compression or blending.
- Product availability and documentation requirements are confirmed for the intended market.
Formulation & analytical development
Pre-formulation, excipient selection, analytical evaluation and stability assessment, with scale-up considered from the outset.
- Pre-formulation, excipient selection, formulation optimisation and process development.
- Analytical evaluation and stability assessment, with the scope defined for each product programme.
- A development pathway from laboratory feasibility through scale-up, technology transfer and process validation to commercial manufacturing.
Have a specific formulation in mind?
Share the active ingredient, intended dosage form, release profile and target market. For intermediates, include the planned next step: capsule filling, compression or blending.